CCK-8-immunoreactivity distribution in human brain: selective decrease in the substantia nigra from parkinsonian patients
Identifieur interne : 005689 ( Main/Exploration ); précédent : 005688; suivant : 005690CCK-8-immunoreactivity distribution in human brain: selective decrease in the substantia nigra from parkinsonian patients
Auteurs : J. M. Studler [France] ; F. Javoy-Agid [France] ; F. Cesselin [France] ; J. C. Legrand [France] ; Yves Agid [France]Source :
- Brain Research [ 0006-8993 ] ; 1982.
Abstract
Abstract: The regional distribution of immunoassayable CCK-8 was determined in 12 regions of control and parkinsonian human brain, with specific attention to the possible regional coexistence of CCK-8 with dopamine. In Parkinson's disease, CCK-8-I levels were only decreased in the substantia nigra where dopamine cell bodies lie, and not in striatal and corticolimbic dopamine projecting areas. Our results suggest that the major proportion of dopaminergic neurones degenerated in Parkinson's disease may not contain the CCK-8 peptide.
Url:
DOI: 10.1016/0006-8993(82)91135-0
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000444
- to stream Istex, to step Curation: 000444
- to stream Istex, to step Checkpoint: 002313
- to stream Main, to step Merge: 006225
- to stream Main, to step Curation: 005689
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">CCK-8-immunoreactivity distribution in human brain: selective decrease in the substantia nigra from parkinsonian patients</title>
<author><name sortKey="Studler, J M" sort="Studler, J M" uniqKey="Studler J" first="J. M." last="Studler">J. M. Studler</name>
</author>
<author><name sortKey="Javoy Agid, F" sort="Javoy Agid, F" uniqKey="Javoy Agid F" first="F." last="Javoy-Agid">F. Javoy-Agid</name>
</author>
<author><name sortKey="Cesselin, F" sort="Cesselin, F" uniqKey="Cesselin F" first="F." last="Cesselin">F. Cesselin</name>
</author>
<author><name sortKey="Legrand, J C" sort="Legrand, J C" uniqKey="Legrand J" first="J. C." last="Legrand">J. C. Legrand</name>
</author>
<author><name sortKey="Agid, Y" sort="Agid, Y" uniqKey="Agid Y" first="Y." last="Agid">Yves Agid</name>
<affiliation><country>France</country>
<placeName><settlement type="city">Paris</settlement>
<region type="region" nuts="2">Île-de-France</region>
</placeName>
<orgName type="hospital" n="4">Hôpital de la Salpêtrière</orgName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:4C27ABA2F9822E4780A996747E0616AB89ADF357</idno>
<date when="1982" year="1982">1982</date>
<idno type="doi">10.1016/0006-8993(82)91135-0</idno>
<idno type="url">https://api.istex.fr/document/4C27ABA2F9822E4780A996747E0616AB89ADF357/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000444</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000444</idno>
<idno type="wicri:Area/Istex/Curation">000444</idno>
<idno type="wicri:Area/Istex/Checkpoint">002313</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">002313</idno>
<idno type="wicri:doubleKey">0006-8993:1982:Studler J:cck:immunoreactivity:distribution</idno>
<idno type="wicri:Area/Main/Merge">006225</idno>
<idno type="wicri:Area/Main/Curation">005689</idno>
<idno type="wicri:Area/Main/Exploration">005689</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">CCK-8-immunoreactivity distribution in human brain: selective decrease in the substantia nigra from parkinsonian patients</title>
<author><name sortKey="Studler, J M" sort="Studler, J M" uniqKey="Studler J" first="J. M." last="Studler">J. M. Studler</name>
<affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>Laboratoire de Biochimie me´dicale, Service du Prof. Legrand, UER, Pitie´-Salpeˆtrie`re, 91</wicri:regionArea>
<wicri:noRegion>91</wicri:noRegion>
<wicri:noRegion>91</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Javoy Agid, F" sort="Javoy Agid, F" uniqKey="Javoy Agid F" first="F." last="Javoy-Agid">F. Javoy-Agid</name>
<affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>Laboratoire de Me´decine expe´rimentale, UER, Pitie´-Salpeˆtrie`re, 91, boulevard de l'Hoˆpital</wicri:regionArea>
<wicri:noRegion>boulevard de l'Hoˆpital</wicri:noRegion>
<wicri:noRegion>boulevard de l'Hoˆpital</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Cesselin, F" sort="Cesselin, F" uniqKey="Cesselin F" first="F." last="Cesselin">F. Cesselin</name>
<affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>Laboratoire de Biochimie me´dicale, Service du Prof. Legrand, UER, Pitie´-Salpeˆtrie`re, 91</wicri:regionArea>
<wicri:noRegion>91</wicri:noRegion>
<wicri:noRegion>91</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Legrand, J C" sort="Legrand, J C" uniqKey="Legrand J" first="J. C." last="Legrand">J. C. Legrand</name>
<affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>Laboratoire de Biochimie me´dicale, Service du Prof. Legrand, UER, Pitie´-Salpeˆtrie`re, 91</wicri:regionArea>
<wicri:noRegion>91</wicri:noRegion>
<wicri:noRegion>91</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Agid, Y" sort="Agid, Y" uniqKey="Agid Y" first="Y." last="Agid">Yves Agid</name>
<affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>Laboratoire de Me´decine expe´rimentale, UER, Pitie´-Salpeˆtrie`re, 91, boulevard de l'Hoˆpital</wicri:regionArea>
<wicri:noRegion>boulevard de l'Hoˆpital</wicri:noRegion>
<wicri:noRegion>boulevard de l'Hoˆpital</wicri:noRegion>
<placeName><settlement type="city">Paris</settlement>
<region type="region" nuts="2">Île-de-France</region>
</placeName>
<orgName type="hospital" n="4">Hôpital de la Salpêtrière</orgName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Brain Research</title>
<title level="j" type="abbrev">BRES</title>
<idno type="ISSN">0006-8993</idno>
<imprint><publisher>ELSEVIER</publisher>
<date type="published" when="1982">1982</date>
<biblScope unit="volume">243</biblScope>
<biblScope unit="issue">1</biblScope>
<biblScope unit="page" from="176">176</biblScope>
<biblScope unit="page" to="179">179</biblScope>
</imprint>
<idno type="ISSN">0006-8993</idno>
</series>
<idno type="istex">4C27ABA2F9822E4780A996747E0616AB89ADF357</idno>
<idno type="DOI">10.1016/0006-8993(82)91135-0</idno>
<idno type="PII">0006-8993(82)91135-0</idno>
<idno type="ArticleID">82911350</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0006-8993</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass></textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Abstract: The regional distribution of immunoassayable CCK-8 was determined in 12 regions of control and parkinsonian human brain, with specific attention to the possible regional coexistence of CCK-8 with dopamine. In Parkinson's disease, CCK-8-I levels were only decreased in the substantia nigra where dopamine cell bodies lie, and not in striatal and corticolimbic dopamine projecting areas. Our results suggest that the major proportion of dopaminergic neurones degenerated in Parkinson's disease may not contain the CCK-8 peptide.</div>
</front>
</TEI>
<affiliations><list><country><li>France</li>
</country>
<region><li>Île-de-France</li>
</region>
<settlement><li>Paris</li>
</settlement>
<orgName><li>Hôpital de la Salpêtrière</li>
</orgName>
</list>
<tree><country name="France"><noRegion><name sortKey="Studler, J M" sort="Studler, J M" uniqKey="Studler J" first="J. M." last="Studler">J. M. Studler</name>
</noRegion>
<name sortKey="Agid, Y" sort="Agid, Y" uniqKey="Agid Y" first="Y." last="Agid">Yves Agid</name>
<name sortKey="Cesselin, F" sort="Cesselin, F" uniqKey="Cesselin F" first="F." last="Cesselin">F. Cesselin</name>
<name sortKey="Javoy Agid, F" sort="Javoy Agid, F" uniqKey="Javoy Agid F" first="F." last="Javoy-Agid">F. Javoy-Agid</name>
<name sortKey="Legrand, J C" sort="Legrand, J C" uniqKey="Legrand J" first="J. C." last="Legrand">J. C. Legrand</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 005689 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 005689 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= ParkinsonFranceV1 |flux= Main |étape= Exploration |type= RBID |clé= ISTEX:4C27ABA2F9822E4780A996747E0616AB89ADF357 |texte= CCK-8-immunoreactivity distribution in human brain: selective decrease in the substantia nigra from parkinsonian patients }}
![]() | This area was generated with Dilib version V0.6.29. | ![]() |